Prelude Therapeutics (PRLD) EPS (Basic) (2019 - 2026)
Prelude Therapeutics (PRLD) reported EPS (Basic) of -$0.42 for Q1 2026, up 44.89% on a YoY basis from -$0.29 in Q1 2025, and down 77.64% sequentially from -$0.23 in Q4 2025.
Prelude Therapeutics (PRLD) EPS (Basic) (2019 - 2026) Analysis & Trends
Prelude Therapeutics (PRLD) has 8 years of EPS (Basic) data on file, last reported at -$0.42 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 44.89% year-over-year to -$0.42; the trailing twelve-month figure through Mar 2026 stood at -$1.81 (up 44.73% YoY), and the FY2025 full-year result was -$4.11, up 3.29% from the prior year.
- EPS (Basic) eased to -$0.42 in Q1 2026, from -$0.23 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.23 in Q4 2025 to a low of -$3.05 in Q4 2022.
- A 5-year average of -$0.85 and a median of -$0.76 in 2025 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) surged 84.32% in 2022 and tumbled 89.52% in 2024, its largest moves.
- Tracing PRLD's EPS (Basic) over 5 years: stood at -$3.05 in 2022, then jumped by 79.43% to -$0.63 in 2023, then grew by 27.74% to -$0.45 in 2024, then soared by 48.17% to -$0.23 in 2025, then plunged by 77.64% to -$0.42 in 2026.
- Business Quant data shows PRLD's EPS (Basic) at -$0.42 in Q1 2026, -$0.23 in Q4 2025, and -$0.55 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Prelude Therapeutics | 318.53 Mn | 173.93 Mn | - | -0.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.42 |
| Dec 31, 2025 | -0.23 |
| Sep 30, 2025 | -0.55 |
| Jun 30, 2025 | -0.72 |
| Mar 31, 2025 | -0.76 |
| Dec 31, 2024 | -0.45 |
| Sep 30, 2024 | -1.01 |
| Jun 30, 2024 | -1.05 |
| Mar 31, 2024 | -1.03 |
| Dec 31, 2023 | -0.63 |
| Sep 30, 2023 | -0.53 |
| Jun 30, 2023 | -0.67 |
| Mar 31, 2023 | -0.80 |
| Dec 31, 2022 | -3.05 |
| Sep 30, 2022 | -0.90 |
| Jun 30, 2022 | -0.79 |
| Mar 31, 2022 | -0.88 |
| Dec 31, 2021 | -2.35 |
| Sep 30, 2021 | -3.67 |
| Jun 30, 2021 | -3.45 |